Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares Repurchased
Ratios

Guardian Pharmacy Services (GRDN) Accumulated Depreciation & Amortization (2023 - 2025)

Guardian Pharmacy Services (GRDN) has disclosed Accumulated Depreciation & Amortization for 3 consecutive years, with $22.3 million as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 12.96% to $22.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $22.3 million through Dec 2025, up 12.96% year-over-year, with the annual reading at $22.3 million for FY2025, 12.96% up from the prior year.
  • Accumulated Depreciation & Amortization hit $22.3 million in Q4 2025 for Guardian Pharmacy Services, up from $19.8 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $22.3 million in Q4 2025 to a low of $18.2 million in Q4 2023.
  • Historically, Accumulated Depreciation & Amortization has averaged $20.1 million across 3 years, with a median of $19.8 million in 2024.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: rose 8.43% in 2024 and later increased 12.96% in 2025.
  • Year by year, Accumulated Depreciation & Amortization stood at $18.2 million in 2023, then rose by 8.43% to $19.8 million in 2024, then increased by 12.96% to $22.3 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for GRDN at $22.3 million in Q4 2025, $19.8 million in Q4 2024, and $18.2 million in Q4 2023.